| http://www.w3.org/ns/prov#value | - other neurological diseases and disorders, such as stroke-related aphasia and tinnitus, we do not expect to start pivotal clinical trials for other applications prior to 2007, and the earliest time at which we might expect to obtain regulatory
|
